Lilly pushing ‘around the clock’ with FDA to get COVID-19 antibody treatment approved
Eli Lilly and Co. already has begun manufacturing the drug and expects to have 1 million doses by December, the executive in charge of COVID-19 research said Friday at IBJ’s Life Sciences Power Breakfast.